The MNCCTN Cancer Research Support Grant is intended to support the development and implementation of interventional cancer clinical trials across MNCCTN partner sites. The program describes three funding pathways (Therapeutic Trial Extension, Expanding Opportunities, and Investigator‑Initiated Non‑Therapeutic Trials) aimed at broadening trial access and reaching populations with high cancer burden or limited representation in research. Applicants begin by submitting a Statement of Intent by email, with additional requirements and timelines provided in the full RFA. Trials supported through the program are required to enroll participants in Minnesota.
Eligibility Criteria:
- Trial requirements and pathway rules are specified in the full RFA document linked on the program page.
- Trials are required to enroll participants in Minnesota (as noted in program FAQs).
Funding Details:
- Supports interventional cancer clinical trials across MNCCTN partner sites; funding offered via multiple pathways (see RFA).
- Funding level/budget specifics are provided in the Full RFA Document on the program page.
Deadline:
- Statement of Intent due: April 26, 2026 (submitted by email; page specifies Sunday, April 26 at 10 p.m.).
Where to go for further information:
- Submit Statement of Intent / contact: mncctn@umn.edu.
- Program details.